Viatris
Viatris Inc. is a global healthcare company focused on providing access to medicines, sustainable operations, and innovative solutions to improve patient health. Formed through the merger of Mylan and Upjohn, a division of Pfizer, Viatris operates in the pharmaceutical sector and offers a diverse portfolio of generic, branded, over-the-counter, and biosimilar products. The company serves a broad range of therapeutic areas, including infectious diseases, oncology, dermatology, and cardiovascular health, across multiple international markets.